Opendata, web and dolomites

CARDIACSENSE SIGNED

A new clinically proven and reliable medical solution for continuous heart arrhythmia and blood pressure monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CARDIACSENSE project word cloud

Explore the words cloud of the CARDIACSENSE project. It provides you a very rough idea of what is the project "CARDIACSENSE" about.

cardiacsense    consists    data    5m    2025    sensitive    vital    unaware    mostly    blood    vision    finger    sensor    ischaemic    jobs    yearly    hypertension    false    health    time    bp    af    detects    training    delivers    stroke    mainly    suffering    launch    risk    solution    800m    boost    20    proven    optical    costing    encountered    ppg    save    lack    heart    innovative    continuous    pressure    adults    sense    500bn    positive    accuracy    finalize    patients    signs    clinically    connectivity    half    israeli    365    wearable    globally    invasive    sharing    fibrillation    monitoring    healthcare    grade    besides    htn    device    start    500    inflating    movements    company    measuring    23    free    revenues    watch    monitor    individuals    atrial    precise    lives    first    pulse    signal    introducing    medical    small    reliably    cardiac    wrist    market    2009    trl6    risks    obtrusive    ltd    artefact    surgery    error    storage    arrhythmia   

Project "CARDIACSENSE" data sheet

The following table provides information about the project.

Coordinator
CARDIACSENSE 

Organization address
address: 4 LESHEM ST
city: CAESARA
postcode: 3079825
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.cardiacsense.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIACSENSE IL (CAESARA) coordinator 50˙000.00

Map

 Project objective

Atrial fibrillation (AF) is the most common heart arrhythmia in adults and a major risk factor for ischaemic stroke (increased by 500%), costing globally around €500Bn/year. On the other hand, Hypertension (HTN) is a condition, mostly encountered in patients suffering from AF, although only half of these individuals have this condition under control, and only 20% are unaware that they have HTN. Besides the health risks associated with these conditions, there is a lack of non-obtrusive, non-inflating, non-invasive, small, precise, easy-to-use devices for continuous monitoring of vital signs, including AF and blood pressure. Cardiac Sense Ltd is an Israeli start-up established in 2009, with a vision of developing innovative non-invasive technology for monitoring vital signs. We are developing CardiacSense (TRL6), a clinically-proven medical solution that reliably delivers non-invasive and non-inflating heart arrhythmia and blood pressure monitoring, 23/365 for as long as needed. It mainly consists of a wearable (a watch), highly sensitive, error-free (introducing an artefact sensor), real-time measuring device, that is non-invasive (no surgery needed), easy to use (no training needed) and allows for a great connectivity (providing easy data storage and sharing). Our solution is based on optical PPG sensor technology to monitor heart AF and BP. In addition, we are the first company to develop a unique artefact sensor that detects finger and wrist movements that affect the PPG signal by increasing false positive results. Our solution thus has a medical grade accuracy level of pulse measurement. Through this project we aim to finalize its development and launch it to the market, with a potential to save around €800M to EU healthcare and save up to 5,000 lives yearly, and to boost our company's growth to €7.5M revenues, and 20 new jobs by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARDIACSENSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARDIACSENSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

COUNTMITMENT (2019)

NATURAL CAPITAL ACCOUNTANCY TO IMPROVE REPORTING AND ENVIRONMENTAL PERFORMANCE

Read More  

PRIVATETRACK (2019)

PRIVATETRACK: Privacy-friendly, low-power intelligent room occupancy detection and people counting.

Read More